Jieli Han
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cytokine Signaling Pathways and Interactions
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 6
- Cytokine Signaling Pathways and Interactions 3
- Cancer Immunotherapy and Biomarkers 2
-
- Psoriasis: Treatment and Pathogenesis 3
- Galectins and Cancer Biology 1
- Toxin Mechanisms and Immunotoxins 1
- Co-authors
- Feng Wu (8 shared papers)Jinshuo Fan (8 shared papers)Zhilei Lv (8 shared papers)Yang Jin (8 shared papers)Mengfei Guo (7 shared papers)Guorong Hu (7 shared papers)Qi Huang (7 shared papers)Juanjuan Xu (4 shared papers)
- Journals
- Scientific Reports (1 paper)Cancer Biomarkers (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)Medical Oncology (1 paper)Frontiers in Physiology (1 paper)
- Partner nations
- China
In The Last Decade
Jieli Han
8 papers receiving 364 citations
Peers
Comparison fields: 5 of 73
- Oncology 165
- Cancer Research 74
- Immunology 97
- Pulmonary and Respiratory Medicine 73
- Infectious Diseases 35
Countries citing papers authored by Jieli Han
This map shows the geographic impact of Jieli Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieli Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieli Han more than expected).
Fields of papers citing papers by Jieli Han
This network shows the impact of papers produced by Jieli Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieli Han. The network helps show where Jieli Han may publish in the future.
Co-authors
The 19 scholars most cited alongside Jieli Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 90 | |
| 2 | 2016 | 89 | |
| 3 | 2016 | 73 | |
| 4 | 2016 | 50 | |
| 5 | IL-17 induces EMT via Stat3 in lung adenocarcinoma. | 2016 | 35 |
| 6 | 2015 | 13 | |
| 7 | 2014 | 10 | |
| 8 | 2015 | 9 |
About Jieli Han
Jieli Han is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 369 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers), NF-κB Signaling Pathways (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Galectins and Cancer Biology (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Cancer Research and Treatments (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Oncology (165 citations), Cancer Research (74 citations), Immunology (97 citations), Pulmonary and Respiratory Medicine (73 citations) and Infectious Diseases (35 citations). Jieli Han has collaborated with scholars based in China. Frequent co-authors include Feng Wu, Jinshuo Fan, Zhilei Lv, Yang Jin, Mengfei Guo, Guorong Hu, Qi Huang, Juanjuan Xu, Limin Duan and Xiuxiu Zhang. Their work appears in journals such as Scientific Reports, Cancer Biomarkers, Journal of Cancer Research and Clinical Oncology, Medical Oncology and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.